This topic contains a solution. Click here to go to the answer

Author Question: In holding a crayon, a toddler is most likely to use a a. pincer grasp. b. palmar grasp. c. ... (Read 78 times)

@Brianna17

  • Hero Member
  • *****
  • Posts: 550
In holding a crayon, a toddler is most likely to use a
  a. pincer grasp.
  b. palmar grasp.
  c. tripod grasp.
  d. bimanual grasp.

Question 2

By age three, the young childs manual control can be characterized by the ability to
  a. build a tower of four to six small blocks and turn doorknobs.
  b. make a bridge with blocks, and correctly place round and square pegs in a pegboard.
  c. make intricate block structures and use a tripod grip.
  d. None of these answers.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nital

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

ANS: A

Answer to Question 2

ANS: B




@Brianna17

  • Member
  • Posts: 550
Reply 2 on: Sep 11, 2018
Great answer, keep it coming :)


alexanderhamilton

  • Member
  • Posts: 334
Reply 3 on: Yesterday
Excellent

 

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Prostaglandins were first isolated from human semen in Sweden in the 1930s. They were so named because the researcher thought that they came from the prostate gland. In fact, prostaglandins exist and are synthesized in almost every cell of the body.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library